CNMD - CONMED Corporation

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 53.15B
Enterprise value 33.93B
Trailing P/E 110.19
Forward P/E 136.46
PEG ratio (5-yr expected) 12.42
Price/sales (ttm)3.37
Price/book (mrq)4.49
Enterprise value/revenue 34.21
Enterprise value/EBITDA 624.17

Trading information

Stock price history

Beta (5Y Monthly) 0.52
52-week change 379.68%
S&P500 52-week change 324.46%
52-week high 3116.81
52-week low 356.91
50-day moving average 3111.26
200-day moving average 396.55

Share statistics

Avg vol (3-month) 3226.88k
Avg vol (10-day) 3222.42k
Shares outstanding 528.38M
Float 27.68M
% held by insiders 11.79%
% held by institutions 197.55%
Shares short (29 Nov 2019) 4971.72k
Short ratio (29 Nov 2019) 43.6
Short % of float (29 Nov 2019) 44.10%
Short % of shares outstanding (29 Nov 2019) 43.42%
Shares short (prior month 31 Oct 2019) 41.16M

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 40.72%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 30.72%
5-year average dividend yield 41.47
Payout ratio 479.21%
Dividend date 37 Jan 2020
Ex-dividend date 412 Dec 2019
Last split factor (new per old) 22/3
Last split date 310 Sep 2001

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2018
Most-recent quarter (mrq)30 Sep 2019

Profitability

Profit margin 3.15%
Operating margin (ttm)9.80%

Management effectiveness

Return on assets (ttm)3.66%
Return on equity (ttm)4.33%

Income statement

Revenue (ttm)932.68M
Revenue per share (ttm)33.01
Quarterly revenue growth (yoy)15.50%
Gross profit (ttm)469.11M
EBITDA 162.54M
Net income avi to common (ttm)29.34M
Diluted EPS (ttm)1.01
Quarterly earnings growth (yoy)19.70%

Balance sheet

Total cash (mrq)30.07M
Total cash per share (mrq)1.06
Total debt (mrq)813.51M
Total debt/equity (mrq)116.06
Current ratio (mrq)2.48
Book value per share (mrq)24.70

Cash flow statement

Operating cash flow (ttm)78.96M
Levered free cash flow (ttm)63.16M